PANCREATIC-CANCER - HOW CAN WE PROGRESS

[1] MOST HUMAN CARCINOMAS OF THE EXOCRINE PANCREAS CONTAIN MUTANT C-K-RAS GENES [J]. CELL, 1988, 53 (04) : 549 - 554

[2] CULLINAN S, 1990, CANCER, V65, P2207, DOI 10.1002/1097-0142(19900515)65:10<2207::AID-CNCR2820651007>3.0.CO

[3] 2-Y

[4] A COMPARISON OF 3 CHEMOTHERAPEUTIC REGIMENS IN THE TREATMENT OF ADVANCED PANCREATIC AND GASTRIC-CARCINOMA - FLUOROURACIL VS FLUOROURACIL AND DOXORUBICIN VS FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 253 (14): : 2061 - 2067

[5] CIS-DIAMINODICHLOROPLATINUM(II) CHEMOTHERAPY FOR ADVANCED ADENOCARCINOMA OF THE UPPER GASTROINTESTINAL-TRACT [J]. ONCOLOGY, 1985, 42 (02) : 69 - 71

[6] KELSEN D, 1991, CANCER, V68, P965, DOI 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO

[7] 2-2

[8] KORC M, 1991, CANCER RES, V51, P6243

[9] KYRIAZIS AP, 1985, CANCER RES, V45, P4354

[10] MARTIN DS, 1985, CANCER TREAT REP, V69, P421

[1] MOST HUMAN CARCINOMAS OF THE EXOCRINE PANCREAS CONTAIN MUTANT C-K-RAS GENES [J]. CELL, 1988, 53 (04) : 549 - 554

[2] CULLINAN S, 1990, CANCER, V65, P2207, DOI 10.1002/1097-0142(19900515)65:10<2207::AID-CNCR2820651007>3.0.CO

[3] 2-Y

[4] A COMPARISON OF 3 CHEMOTHERAPEUTIC REGIMENS IN THE TREATMENT OF ADVANCED PANCREATIC AND GASTRIC-CARCINOMA - FLUOROURACIL VS FLUOROURACIL AND DOXORUBICIN VS FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 253 (14): : 2061 - 2067

[5] CIS-DIAMINODICHLOROPLATINUM(II) CHEMOTHERAPY FOR ADVANCED ADENOCARCINOMA OF THE UPPER GASTROINTESTINAL-TRACT [J]. ONCOLOGY, 1985, 42 (02) : 69 - 71

[6] KELSEN D, 1991, CANCER, V68, P965, DOI 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO

[7] 2-2

[8] KORC M, 1991, CANCER RES, V51, P6243

[9] KYRIAZIS AP, 1985, CANCER RES, V45, P4354

[10] MARTIN DS, 1985, CANCER TREAT REP, V69, P421